ELAPR002f Injectable Gel in the Treatment of Atrophic Acne Scars

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

157

Participants

Timeline

Start Date

November 21, 2023

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2026

Conditions
Atrophic Acne Scars
Interventions
DEVICE

ELAPR002f Injectable Gel

Intradermal Injections

OTHER

Saline Active Control

Intradermal Injections

Trial Locations (12)

15831

Dermatologische Gemeinschaftspraxis Mahlow /ID# 262566, Blankenfelde-Mahlow

40212

Privatpraxis Dr. Hilton & Partner /ID# 227472, Düsseldorf

61440

MediCorium Zentrum fuer Dermatologie und Aesthetik /ID# 227475, Oberursel

64283

Rosenpark Research /ID# 227471, Darmstadt

80333

Hautok and Hautok-cosmetics /ID# 227474, Munich

T6G 1C3

Alberta DermaSurgery Centre /ID# 243168, Edmonton

V5Z 4E1

Humphrey & Beleznay Cosmetic Dermatology /ID# 266634, Vancouver

V6H 4E1

Pacific Derm /ID# 227467, Vancouver

L7N 3N2

Dermetics Cosmetic Dermatology /ID# 227469, Burlington

L6J 7W5

The Centre For Clinical Trials /ID# 233841, Oakville

L4B 1A5

The Center For Dermatology /ID# 227470, Richmond Hill

L4L 8E2

Bertucci MedSpa Inc. /ID# 227468, Woodbridge

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AbbVie

INDUSTRY